The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

BACKGROUND: Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. This retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyaratnam, Jerold, ter Haar, Nienke M., Lachmann, Helen J., Kasapcopur, Ozgur, Ombrello, Amanda K., Rigante, Donato, Dedeoglu, Fatma, Baris, Ezgi H., Vastert, Sebastiaan J., Wulffraat, Nico M., Frenkel, Joost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863478/
https://www.ncbi.nlm.nih.gov/pubmed/29562920
http://dx.doi.org/10.1186/s12969-018-0235-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863478/
https://www.ncbi.nlm.nih.gov/pubmed/29562920
http://dx.doi.org/10.1186/s12969-018-0235-z

Ejemplares similares